18:44:29 EST Wed 30 Nov 2022
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
Tripsitter Clinic Ltd
Symbol KETA
Shares Issued 30,290,868
Close 2022-06-02 C$ 0.05
Recent Sedar Documents

Tripsitter Clinic launches ketamine therapy app

2022-06-03 10:33 ET - News Release

Dr. John Huber reports

TRIPSITTER.CLINIC LAUNCHES NEW APP FOR AT-HOME KETAMINE THERAPY

Tripsitter Clinic Ltd. has officially launched the Tripsitter app, a simple and free app that makes it easy for users to access Tripsitter Clinics' services.

Chief executive officer of Tripsitter Clinic Dr. John Huber stated, "We are delighted to announce our new app launch which will enable users with a convenient platform for patients to connect to a doctor, and then be guided along their psychedelic healing journey with specially trained Tripsitters.

The app is available to users through Apple's app store and Google's Play store. The app features a compatibility assessment so patients will be matched with Tripsitters that share common interests and personalities. The app features secure telehealth and unlimited messaging between patients and their Tripsitter and also enables scheduling, medication tracking and billing

Tripsitter Clinic is currently operating in Alabama, Arizona, California , Colorado, Florida, Georgia, Illinois, Indiana, Iowa, Kansas, Kentucky, Maine, Michigan, Minnesota, Mississippi, Montana, Nebraska, New Hampshire, New York, North Dakota, Ohio, Oklahoma, Pennsylvania, Tennessee, Texas, Vermont, Virginia, Washington, West Virginia, Wisconsin and Wyoming with continued expansion across the United States over the next six months.

About Tripsitter Clinic Ltd.

Tripsitter Clinic, through its wholly owned subsidiary Tripsitter Clinic Corp., is at the forefront of two emerging sectors: telehealth and psychedelic medicine. The company's consultative virtual clinic, Tripsitter.Clinic, is an internationally recognized software-as-a-service platform that provides care, monitoring and coaching while connecting patients with licensed physicians in the United States who can evaluate for a prescribed psychedelic treatment program of therapeutic low-dose ketamine medication. Tripsitter is not a primary care physician (PCP). Tripsitter.Clinic requires prospective patients to provide a diagnosis from their PCP along with other health information to their chosen Tripsitter physician during the initial intake process. When a patient is approved for treatment by their physician, Tripsitter.Clinic connects the patient with experts who also use the platform to consult and co-ordinate with the patient and their physician.

We seek Safe Harbor.

© 2022 Canjex Publishing Ltd. All rights reserved.